Profile data is unavailable for this security.
About the company
Wuhan Keqian Biology Co Ltd is a China-based company mainly engaged in the research and development, production, sales of veterinary biological products and the provision of animal epidemic prevention technical services. The Company's main products are vaccines for swine and poultry. The Company mainly conducts its businesses within the China market.
- Revenue in CNY (TTM)932.75m
- Net income in CNY309.38m
- Incorporated2001
- Employees923.00
- LocationWuhan Keqian Biology Co LtdNo. 419, Gaoxin 2nd Road, DonghuNew Technology Development ZoneWUHAN 430073ChinaCHN
- Phone+86 2 781322905
- Fax+86 2 781322905
- Websitehttp://www.kqbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Haoyuan Chemexpress Co Ltd | 2.05bn | 103.00m | 5.02bn | 3.37k | 48.58 | 1.92 | -- | 2.44 | 0.4911 | 0.4911 | 9.79 | 12.45 | 0.4922 | 1.03 | 3.90 | 609,696.60 | 2.43 | 7.38 | 3.29 | 9.60 | 42.71 | 47.03 | 4.93 | 13.53 | 0.9905 | 3.08 | 0.3088 | 14.37 | 38.44 | 44.33 | -34.18 | 47.24 | 48.95 | -- |
| Wuhan Keqian Biology Co Ltd | 932.75m | 309.38m | 5.28bn | 923.00 | 16.96 | 1.40 | -- | 5.66 | 0.6681 | 0.6681 | 2.01 | 8.07 | 0.2072 | 2.09 | 2.79 | 1,010,559.00 | 6.86 | 13.29 | 8.07 | 15.49 | 66.77 | 76.49 | 33.11 | 45.71 | 3.93 | -- | 0.0637 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
| Cisen Pharmaceutical Co Ltd | 4.31bn | 527.50m | 5.36bn | 3.40k | 10.19 | 0.9223 | -- | 1.24 | 1.16 | 1.16 | 9.49 | 12.83 | 0.6071 | 2.29 | 5.67 | 1,267,832.00 | 7.49 | 6.94 | 9.20 | 8.56 | 58.78 | 56.27 | 12.34 | 10.77 | 2.96 | -- | 0.0551 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 840.44m | 273.54m | 5.47bn | 1.17k | 20.00 | 2.36 | -- | 6.51 | 0.3295 | 0.3295 | 1.01 | 2.80 | 0.2804 | 1.09 | 3.13 | 715,880.10 | 9.13 | 9.38 | 12.03 | 12.84 | 55.25 | 53.09 | 32.55 | 27.14 | 2.16 | -- | 0.1259 | 23.53 | 6.83 | 27.35 | 7.87 | 42.07 | 24.32 | 50.48 |
| Shanghai Yizhong Pharmaceutical Co Ltd | 281.75m | 91.95m | 5.59bn | 43.00 | 60.94 | 3.83 | -- | 19.84 | 0.4457 | 0.4457 | 1.37 | 7.10 | 0.1887 | 0.7719 | 2.23 | 6,552,222.00 | 6.16 | -0.9181 | 6.42 | -0.9485 | 93.75 | 93.19 | 32.64 | -6.11 | 12.37 | -- | 0.0214 | -- | 52.68 | -- | 13.09 | -- | 20.44 | -- |
Data as of Sep 20 2024. Currency figures normalised to Wuhan Keqian Biology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 4.57m | 0.98% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 3.25m | 0.70% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 2.92m | 0.63% |
| Caitong Fund Management Co., Ltd.as of 31 Dec 2023 | 2.89m | 0.62% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 2.07m | 0.44% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.52m | 0.33% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.11m | 0.24% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 764.62k | 0.16% |
| The Vanguard Group, Inc.as of 04 Sep 2024 | 737.49k | 0.16% |
| CITIC-Prudential Fund Management Co., Ltd.as of 31 Dec 2023 | 715.01k | 0.15% |
More ▼
Data from 31 Dec 2023 - 19 Sep 2024Source: FactSet Research Systems Inc.
